Implications of Somatostatin Analogues in the Treatment of Acromegaly

Eur Endocrinol. 2013 Aug;9(2):132-135. doi: 10.17925/EE.2013.09.02.132. Epub 2013 Aug 23.


Octreotide has an important role in the medical management of acromegaly. Its place in the management of acromegaly as an adjuvant therapy after neurosurgery is well established with a well-demonstrated efficacy. It can also be used in certain clinical conditions as a neoadjuvant treatment. Clinicians and patients should be aware of the possible side effects of octreotide treatment.

Keywords: Acromegaly; octreotide; side effects; somatostatin analogues; treatment.

Publication types

  • Review